Cached score snapshot

US.EW · Edwards Lifesciences

110分制 67.1/110；5D動能v2 20/50；排序分 87.1/160

Back to ranking Open volume snapshot

Ranking score 87.1/160

Main score 67.1/110

5D momentum v2 20/50

Rank #21

Setup grade D 45

Score breakdown

謹慎買入

Medium database-backfill

Score and price trend

D 45 Money flow A · Technical A · Low sample confidence

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

**Historical projection**
Model	Median	P25/P75	歷史相似情境上漲比例	Down5	Actual / compare
Rolling DOE best · score 2.469 · anchors 120	-0.10%	-1.98% / +2.01%	47.8%	6.8%	Actual +0.21% · vs median +0.31% · inside 25-75 band
30D observation	-0.02%	-5.52% / +10.54%	49.6%	27.4%	Actual outcome pending · 21 / 30 bars observed
Historical projection 10D n=160	+0.07%	-2.25% / +2.13%	50.6%	10%	Actual +0.08% · vs median +0.01% · inside 25-75 band

歷史情境統計基於已存檔相似 setup；圖中投影中位線為統計中位數的線性插值展示，並非價格路徑預測或買賣建議。

2026-02-27 → 2026-07-07 · 177 archived points · 7 Deteriorating signal

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 87.1

Display grade 謹慎買入

Model version cursor_18_27_news_v2_160

Main score 67.1/110 (謹慎買入)

5D momentum v2 20/50 (中)

Score with momentum v2 87.1/160 (低排序)

Risk level Medium

Audit trace

Full calculation detail

Calculation detail · 4 sections

Market inputs

Bar count 229

ma20 82.2055

ma50 81.458

close 85.78

prevClose 83.2

avgVolume20 4745440

volumeRatio 1.04

changePercent 3.1

Metrics snapshot

close 85.78

volume 4941700

changePercent 3.1

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 67.1/110

Main rating 謹慎買入

5D momentum v2 20/50

Score with momentum v2 87.1/160

Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 3.1/5 · 一般

Dimension score 3.1/5

Dimension grade 一般

No sub-item breakdown recorded.

資金流 — 15.6/20 · 良好

Dimension score 15.6/20

Dimension grade 良好

No sub-item breakdown recorded.

市場環境 — 10.2/15 · 一般

Dimension score 10.2/15

Dimension grade 一般

No sub-item breakdown recorded.

催化劑 — 2/20 · 較差

Dimension score 2/20

Dimension grade 較差

No sub-item breakdown recorded.

風險管理 — 7.2/10 · 良好

Dimension score 7.2/10

Dimension grade 良好

No sub-item breakdown recorded.

技術信號 — 23/30 · 良好

Dimension score 23/30

Dimension grade 良好

No sub-item breakdown recorded.

情緒分析 — 6/10 · 一般

Dimension score 6/10

Dimension grade 一般

No sub-item breakdown recorded.

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 20/50

ret_5d 0.0541

raw_total 20

vcp_bonus 0

ret_points 8

vol_points 0

breakout_points 8

Risk management

level Medium

reason risk management score >= 6.5/10

position

score 1.6

details

atrPct 2.9128

turnoverUsdM 423.899

liquidityPoints 0.6

volatilityPoints 1

rrPoints 1.8

stopLevels

symbol US.EW

rr_range 1:1.0-1:2.5

risk_profile 中等

stop_loss_price 80.7828

strength_details

ma_score 2

atr_score 2

rsi_score 2

macd_score 3

volume_score 2

market_adjustment 1

risk_reward_ratio 1.7

stop_loss_percent 5.8

take_profit_price 94.0254

target_multiplier 2.2

technical_strength 2.25

take_profit_percent 9.6

positionPoints 1.6

stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used

sector Health Care

concentratedSectorPenalty 0

riskRewardRatio 1.6479

stopLossPercent 5.8256

diversificationPoints 2

Raw calculation JSON

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.6,
      "details": {
        "atrPct": 2.9128001865236652,
        "turnoverUsdM": 423.899026,
        "liquidityPoints": 0.6,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.8,
    "stopLevels": {
      "symbol": "US.EW",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 80.7828,
      "strength_details": {
        "ma_score": 2,
        "atr_score": 2,
        "rsi_score": 2,
        "macd_score": 3,
        "volume_score": 2
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.7,
      "stop_loss_percent": 5.8,
      "take_profit_price": 94.0254,
      "target_multiplier": 2.2,
      "technical_strength": 2.25,
      "take_profit_percent": 9.6
    },
    "positionPoints": 1.6,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.647898823341071,
    "stopLossPercent": 5.8256003730473305,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 87.1,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 67.1,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 20
  },
  "market": {
    "ma20": 82.2055,
    "ma50": 81.458,
    "close": 85.78,
    "prevClose": 83.2,
    "avgVolume20": 4745440,
    "volumeRatio": 1.04,
    "changePercent": 3.1
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 229,
  "momentum": {
    "max": 50,
    "result": 20,
    "details": {
      "ret_5d": 0.05406733841238642,
      "raw_total": 20,
      "vcp_bonus": 0,
      "ret_points": 8,
      "vol_points": 0,
      "breakout_points": 8
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "謹慎買入",
    "result": 67.1,
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 3.1,
      "資金流": 15.6,
      "市場環境": 10.2,
      "情緒分析": 6,
      "技術信號": 23,
      "風險管理": 7.2
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差"
      },
      "基本面": {
        "max": 5,
        "grade": "一般",
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "良好"
      },
      "市場環境": {
        "max": 15,
        "grade": "一般"
      },
      "情緒分析": {
        "max": 10,
        "grade": "一般"
      },
      "技術信號": {
        "max": 30,
        "grade": "良好"
      },
      "風險管理": {
        "max": 10,
        "grade": "良好"
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ]
  }
}

Raw metrics JSON

{
  "close": 85.78,
  "volume": 4941700,
  "changePercent": 3.1
}

Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.